American College of Cardiology annual meeting: Music still playing for the LDL limbo
American College of Cardiology annual meeting,March 6–9, Orlando
Music still playing for the LDL limbo
Over the course of a decade or so, the first generation of statin studies identified who benefits from these cholesterol-lowering drugs. The second generation has a different emphasis: How far should LDL (bad) cholesterol be lowered?
Since 1993, national guidelines set out three main targets for LDL — under 160 mg/dL for people with no heart disease and low heart-attack risk, under 130 for people with no heart disease but at moderate heart-attack risk, and under 100 for those with heart disease or at high risk for it.
To continue reading this article, you must log in.
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.
- Research health conditions
- Check your symptoms
- Prepare for a doctor's visit or test
- Find the best treatments and procedures for you
- Explore options for better nutrition and exercise
I'd like to receive access to Harvard Health Online for only $4.99 a month.
Sign Me UpAlready a member? Login ».
Disclaimer:
As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles.
No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.